Kwang Bum Cho

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Kyung In Shin · 2 shared papers, 2026 · strength 0.83
   • Paper Clinical and prognostic implications of KRT19 expression in pancreatic ductal adenocarcinoma. DOI 10.21037/tcr-2025-1-2629↗
   • Paper Bile-derived RNA N6-methyladenosine (m6A) methylation as a novel liquid biopsy biomarker for pancreatic cancer DOI 10.3389/fonc.2026.1955611↗
2. Hyung Jun An · 1 shared paper, 2026 · strength 0.50
   • Paper Clinical and prognostic implications of KRT19 expression in pancreatic ductal adenocarcinoma. DOI 10.21037/tcr-2025-1-2629↗
3. Jin-Yi Han¹ · 1 shared paper, 2026 · strength 0.33
   • Paper Bile-derived RNA N6-methyladenosine (m6A) methylation as a novel liquid biopsy biomarker for pancreatic cancer DOI 10.3389/fonc.2026.1955611↗
4. Keun Soo Ahn · 1 shared paper, 2026 · strength 0.33
   • Paper Bile-derived RNA N6-methyladenosine (m6A) methylation as a novel liquid biopsy biomarker for pancreatic cancer DOI 10.3389/fonc.2026.1955611↗
5. Seung Woo Park · 1 shared paper, 2017 · strength 0.05
   • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
6. Si Young Song · 1 shared paper, 2017 · strength 0.05
   • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
7. Hee Seung Lee · 1 shared paper, 2017 · strength 0.05
   • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
8. Chang Duck Kim · 1 shared paper, 2017 · strength 0.05
   • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
9. Jong Ho Moon · 1 shared paper, 2017 · strength 0.05
   • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
10. Moon Jae Chung · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
11. Dong Uk Kim · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
12. Jeong Youp Park · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
13. Sang Hyub Lee · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
14. Ho Gak Kim · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
15. Young Koog Cheon · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
16. Ho Soon Choi · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
17. Dong Ki Lee · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
18. Yong‐Tae Kim · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
19. Seungmin Bang · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
20. Chang Min Cho · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.